Niacin in cardiovascular prevention: mechanisms, efficacy, and safety

被引:84
作者
Guyton, John R. [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
关键词
coronary heart disease; dyslipidemia; G-protein-coupled receptor; niacin; nicotinic acid;
D O I
10.1097/MOL.0b013e3282364add
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Recently developed understanding of the mechanisms, efficacy, and safety of niacin, along with progress in reducing the chief side effect of flushing, should enhance the use of this valuable agent for cardiovascular prevention.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 70 条
[1]
Adler AI, 1999, AM HEART J, V138, pS353
[2]
ISLET-ACTIVATING PROTEIN PREVENTS NICOTINIC ACID-INDUCED GTPASE STIMULATION AND GTP BUT NOT GTP-GAMMA-S-INDUCED ADENYLATE-CYCLASE INHIBITION IN RAT ADIPOCYTES [J].
AKTORIES, K ;
SCHULTZ, G ;
JAKOBS, KH .
FEBS LETTERS, 1983, 156 (01) :88-92
[3]
Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system) [J].
Alsheikh-Ali, Alawi A. ;
Karas, Richard H. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (03) :379-381
[4]
INFLUENCE OF NICOTINIC ACID ON SERUM CHOLESTEROL IN MAN [J].
ALTSCHUL, R ;
HOFFER, A ;
STEPHEN, JD .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1955, 54 (02) :558-559
[5]
Impact of nicotinic acid treatment on insulin secretion and insulin sensitivity in low and high insulin responders [J].
Alvarsson, M ;
Grill, V .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (06) :563-570
[6]
[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
[7]
GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing [J].
Benyó, Z ;
Gille, A ;
Kero, J ;
Csiky, M ;
Suchánková, MC ;
Nüsing, RM ;
Moers, A ;
Pfeffer, K ;
Offermanns, S .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (12) :3634-3640
[8]
Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells [J].
Benyo, Zoltan ;
Gille, Andreas ;
Bennett, Clare L. ;
Clausen, Bjoern E. ;
Offermanns, Stefan .
MOLECULAR PHARMACOLOGY, 2006, 70 (06) :1844-1849
[9]
BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240
[10]
Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials [J].
Brown, B. Greg ;
Stukovsky, Karen Hinckley ;
Zhao, Xue-Qiao .
CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (06) :631-636